TFEB and colorectal carcinoma: The CCK-8 assay showed that CRC cells overexpressing both WT and mutant TFEB displayed a pro-proliferation phenotype, as compared to the control, while TFEBS138A/S142A displayed a higher proliferation ability than TFEBWT cells (Figure 1F), suggesting an oncogenic role of activated TFEB in CRC.